
Eculizumab epitope on complement C5: Progress towards a better understanding of the mechanism of action
Keywords: ماکروگلوبولین; aHUS; atypical hemolytic and uremic syndrome; C5; complement protein C5; CDR; complementarity determining region; CVF; cobra venom factor; DMSO; dimethylsulfoxyde; ECZ; eculizumab; Fab; fragment antigen binding; Fv; fragment variable; mAb; monoclonal anti